Skip to main content
SHIFT Newsroom
Read the latest published stories →Medicine news and evidence →

3 NHS weight loss drugs: who qualifies, why it depends on your postcode

Published 24 September 2026 · SHIFT Team

Decorative NHS weight loss pathway illustration

Yes, the NHS prescribes weight loss medication, and three names matter most: tirzepatide (Mounjaro®), semaglutide (Wegovy®) and liraglutide (Saxenda®). Access depends on your BMI, your health conditions, and increasingly on where you live, because the rollout is happening in stages through local Integrated Care Boards. Every prescription comes bundled with behavioural support. Check your local ICB pathway and talk to your GP before assuming you qualify.

TL;DR:

- NHS prescribing of tirzepatide is expanding to GPs in many areas, while semaglutide and liraglutide mostly still require specialist referrals.
- Eligibility depends on BMI thresholds that vary by ethnicity and health conditions, with higher priority given to those with more severe obesity and comorbidities.
- The process involves assessments by GPs or specialist services, with preparation on weight history, health conditions, and medication lists advisable before appointments.
- Weight loss medications include side effects like nausea and digestive issues, which usually improve over time, but serious risks like pancreatitis are rare.
- Access varies significantly by postcode due to local rollout differences, with private options available but they lack NHS wraparound support and regulation.

Table of Contents

Which NHS weight loss medications are available and how they work

All three medicines belong to a family called GLP-1 receptor agonists, or in tirzepatide's case, a dual GIP/GLP-1 agonist. They work by mimicking hormones your gut releases after eating, which slows down stomach emptying, dulls appetite, and helps you feel fuller for longer. Some also improve blood sugar control, which is why several started life as diabetes treatments before being repurposed for weight management.

Where you get each one depends on which drug it is:

Your GP can now prescribe tirzepatide directly for eligible patients in many areas, but Wegovy and Saxenda usually still mean a referral to a specialist service first. That distinction catches a lot of people out.

Who qualifies for NHS weight loss treatment right now

Eligibility isn't a single number. NICE's TA1026 guidance sets BMI thresholds, but those thresholds shift depending on your ethnicity and how many weight-related health problems you already carry.

Broadly, you're looking at:

There's also a built-in checkpoint: after six months on the maximum tolerated dose, your prescriber reviews progress.

How to actually get these medicines through the NHS

The route depends on which drug you're after and how your local ICB has set things up, but the shape of it is fairly consistent across England.

For tirzepatide, many people now start with their GP, who runs an assessment covering weight history, BMI, blood pressure and existing conditions, alongside baseline blood tests. Some areas route this through a Specialist Weight Management Service (SWMS) instead, particularly where the local ICB hasn't yet enabled direct GP prescribing. For Wegovy and Saxenda, expect a referral to a SWMS as the default rather than the exception, as explained in this comparison of GP versus specialist weight-management routes.

Before your appointment, it helps to prepare properly:

  1. Note your current weight, height and any weight history over the past two to three years.
  2. List existing diagnoses, particularly diabetes, high blood pressure, sleep apnoea or joint problems.
  3. Bring a current medication list, including anything bought over the counter.
  4. Ask directly which drug your surgery or local service prescribes, and whether behavioural support is included automatically.
  5. Ask what monitoring schedule you'll be on and when the six-month review happens.

Pro Tip: Ring your GP surgery before booking and ask if they're currently part of the tirzepatide primary care rollout. Some practices are still waiting for their ICB to switch this on, and knowing that in advance saves you a wasted appointment.

What NHS treatment actually involves once you're prescribed

Getting the prescription is only the start. NHS weight loss medication always comes with wraparound care, split into two parts: clinical monitoring and behavioural support. The behavioural side might be delivered through the nationally procured Healthier You programme or a local equivalent, and it covers diet, activity and psychological support, not just a script and a follow-up call, according to NHS England's guidance on wraparound care.

Two-part NHS weight loss support pathway

Expect regular check-ins as your dose is titrated upward, with blood pressure, weight and side effects reviewed at each stage.

Most people experience some combination of nausea, diarrhoea, vomiting or constipation, especially in the first few weeks. These usually settle as your body adjusts.

Any suspected side effect worth flagging should go through the MHRA Yellow Card scheme, the UK's official reporting system for adverse drug reactions. It's how regulators spot patterns that individual GPs might miss.

The postcode reality: why access varies so much

Here's the part most explainers skip. NICE and NHS England set the national framework, but each ICB decides how quickly to roll it out locally, how many GP practices can prescribe, and how big their specialist service capacity is.

Healthwatch reporting describes exactly what you'd expect from that setup: a genuine postcode lottery, where some patients get seen quickly and others face long waits or find their GP simply isn't part of the rollout yet. That's pushed a meaningful number of people towards private prescriptions instead.

Private routes exist and can move faster, but they come with trade-offs worth weighing honestly:

A closer look at NHS versus private weight-loss medication covers this trade-off in more depth if you're weighing your options.

— Matt O’Brien

Why buying weight loss drugs online is never worth the risk

The MHRA has been explicit: don't buy weight loss injections through social media adverts or unregulated online sellers, even when they're being sold as authorised brands. Counterfeit pens, wrong dosing, and products with no clinical oversight have all turned up through these channels, and there's no wraparound care to catch problems early.

If you've used something bought this way and feel unwell, don't wait it out.

Why medication alone rarely finishes the job

The NHS pathway gets the clinical side right: proper assessment, monitored dosing, structured review at six months. What it can't always guarantee, especially given how stretched local services are, is the sustained day-to-day support that determines whether weight loss actually holds once treatment ends.

There is a gap between NHS clinical treatment and sustained day-to-day support. Some programmes pair clinical information with practical structure through food guidance, movement support, personal goal-setting, and progress tracking, with prescribing and dispensing handled by appropriately regulated partners. It's designed for men navigating NHS routes, private routes, or the tricky business of stepping down from medication without sliding backwards.

Support can be available before treatment, during it, and afterwards, including for those who started elsewhere or have already stopped medication and want to maintain their progress.

Why medication alone rarely finishes the job — overview diagram

Get clarity on your options before your next GP appointment

Deciding whether a GP-led route or a specialist weight-management service is more suitable isn't obvious from the outside, and getting it wrong can cause delays. Some services provide straightforward, jargon-free comparisons of both routes to help you prepare for your appointment.

Shift Some Timber Ltd

Unlike a one-off NHS consultation, SHIFT's support doesn't stop once a prescription is issued. The Programme keeps working alongside you through Grub, Fit, Life Back and My Timber, so the habits that keep weight off get built at the same time as the medication does its job, not left to chance afterwards. If you're weighing up whether primary care or a specialist service suits your situation, the GP versus specialist weight-management comparison is the place to start. From there, the Weight-Loss Decision Centre walks you through an assessment to see what fits.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

FAQ

Who is eligible for NHS weight loss injections in 2026?

Eligibility generally requires a BMI of 35 or above with a weight-related health condition, or a BMI of 30 or above in some cohorts, with the threshold lowered to 27.5 for several ethnic groups at higher risk of weight-related illness. The rollout is staged, so people with more comorbidities and higher BMI tend to be prioritised first.

Who qualifies for Mounjaro on the NHS?

Mounjaro follows the same NICE-set thresholds as other NHS weight loss medications, but it's the drug currently being extended into GP prescribing rather than staying specialist-only. Your GP can check whether your practice is part of the primary care rollout for your area.

What's the best weight loss drug in the UK?

There's no single "best" drug because tirzepatide, semaglutide and liraglutide suit different people depending on health history, tolerance and prescribing route available locally. A GP or specialist weight-management service is best placed to match the medicine to your circumstances rather than picking one in isolation.

What new weight loss medications will be approved in 2026?

No new medication approvals beyond the current NICE-recommended options have been confirmed for the NHS at this stage. The safest way to stay current is checking NHS England's published guidance directly rather than relying on secondhand claims.

Can I get weight loss drugs from my GP without a specialist referral?

For tirzepatide, increasingly yes, depending on whether your local ICB has enabled primary care prescribing. For Wegovy and Saxenda, a referral to a specialist weight management service is still the more common route, as outlined in ICB prescribing guidance.